What makes Tindamax® different?

Switch to mobile view »

Tindamax® is easy to take

Tindamax® is an easy, convenient treatment for bacterial vaginosis (BV). It is available in 2 oral dose schedules: 1 gram (2 tablets) once daily for 5 days or 2 grams (4 tablets) once daily for 2 days. Your doctor will know which is right for you.

Tindamax® is also easy on your system, with a low incidence of side effects such as nausea, vomiting, and diarrhea.1

Tindamax® targets and protects

The vagina normally contains a balance of both "good" and "bad" bacteria that make up the vaginal flora. If this balance is altered by changes in sexual behavior or other risk factors, overgrowth of harmful bacteria (i.e., Gardnerella vaginalis) and reductions in good bacteria (lactobacilli) can lead to infections such as BV.2

Tindamax® targets and stops the growth of disease-causing pathogens. Just as importantly, it protects the good bacteria still present in the vaginal flora, which helps to support a healthier vaginal environment.

Tindamax® treats more than just BV

Trichomoniasis

Tindamax® is also a widely used, proven treatment for trichomoniasis (TV), a vaginal infection caused by the organism Trichomonas vaginalis. TV (or "trich") is the most common non-viral sexually transmitted disease in the US, with an estimated 7.4 million new cases every year.3 Studies show that many patients with TV also have BV — in fact, the frequency of dual infection ranges from 24%-57%.4-8

Tindamax® is the only medication approved to treat both BV and TV.

Giardiasis (giardia)

Giardiasis is a highly contagious cause of diarrhea that often strikes travelers, campers and hikers, swimmers in public pools, individuals who drink contaminated water, and children in day care centers.9 Giardia infection is the most commonly reported pathogenic protozoan disease in the United States.10

Amebiasis

Each year, amebiasis affects approximately 50 million people worldwide.11 Caused by a parasite called Entamoeba histolytica, the disease is typically spread by ingesting food or water contaminated with fecal matter from an infected person.

  1. Data on file. Mission Pharmacal Company.
  2. Sweet RL. Gynecologic conditions and bacterial vaginosis: implications for the non-pregnant patient. Infect Dis Obstet Gynecol. 2000;8(3-4):184-90.
  3. Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health. 2004 Jan-Feb;36(1):6-10.
  4. Krieger JN, Tam MR, Stevens CE, Nielsen IO, Hale J, Kiviat NB, Holmes KK. Diagnosis of trichomoniasis. Comparison of conventional wet-mount examination with cytologic studies, cultures, and monoclonal antibody staining of direct specimens. JAMA. 1988 Feb 26;259(8):1223-7.
  5. Hillier SL, Krohn MA, Nugent RP, Gibbs RS. Characteristics of three vaginal flora patterns assessed by gram stain among pregnant women. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol. 1992 Mar;166(3):938-44.
  6. Dan M, Sobel JD. Trichomoniasis as seen in a chronic vaginitis clinic. Infect Dis Obstet Gynecol. 1996;4(2):77-84.
  7. Heine RP, McGregor JA, Patterson E, Draper D, French J, Jones W. Trichomonas vaginalis: Diagnosis and Clinical Characteristics in Pregnancy. Infect Dis Obstet Gynecol. 1994;1(5):228-34.
  8. Demirezen S, Korkmaz E, Beksaç MS. Association between trichomoniasis and bacterial vaginosis: examination of 600 cervicovaginal smears. Cent Eur J Public Health. 2005 Jun;13(2):96-8.
  9. Giardia Infection [Internet]. CDC; 2004 [accessed 2008 July 10]. Available from: http://www.cdc.gov/ncidod/dpd/parasites/giardiasis/2004_PDF_Giardiasis.pdf
  10. Gradus MS. Water quality and waterborne protozoa. Clin Microbiol News 1989;11:121-125.
  11. Bercu TE, Petri WA, Behm JW. Amebic colitis: new insights into pathogenesis and treatment. Curr Gastroenterol Rep. 2007 Oct;9(5):429-33.

Fact Sheets

Websites

For Health Professionals

Only Tindamax® is approved to treat both bacterial vaginosis and trichomoniasis (TV).

Clinical Insight

Oral vs vaginal cream therapy: Patient preference for oral dosing is demonstrated to be 84%. More»

Beyond BV

Tindamax® may be prescribed for other infections including:

The Mission Pharmacal family of products

Learn more about innovative therapies including...

CitraNatal®Calcium citrate with vital nutrients for mother and baby » Ferralet® 90The iron therapy with biocomplementary absorption » Urocit®-KKidney stone therapy with wax-matrix delivery for slow, sustained release »